ロード中...
Predictability of 21-Gene Recurrence Score Assay by Using Pathological and Immunohistochemical Parameters in Breast Cancer
BACKGROUND: Oncotype Dx is used to predict the long-term recurrence risk in patients with estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative invasive breast cancer (BC). This study aimed at establishing a correlation between clinicopathological parameters an...
保存先:
| 出版年: | Breast Cancer (Auckl) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7727040/ https://ncbi.nlm.nih.gov/pubmed/33343196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1178223420977848 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|